Valbiotis Logo

Valbiotis

ISIN

FR0013254851

Ticker

ALVAL

Sector

Health Care

Sub-Industry

Biotechnology

Country

France

Year Founded

2014

About Valbiotis

Company Description

Valbiotis is a Research & Development company dedicated to scientific innovation for preventing and combating metabolic and cardiovascular diseases.

To achieve this goal, Valbiotis has developed an exclusive and unique scientific approach founded on specific combinations of plant-based molecules. The active substances, which are called “Totum”, act directly on the key metabolic parameters of the body. Our unique approach focuses on prevention by providing health nutrition solutions.

Headcount

47

Served Area

Worldwide

Headquarters

ZI des Quatre Chevaliers 12F Rue Paul Vatine
17180, Périgny
France

Insider Trades

Date Trading entity / Person Association Trade type Volume
17.01.2023 None Other Other EUR 46,072.00

Capital Markets Information

ISIN

FR0013254851

LEI

969500VP4JBJCF0MOP60

Sub-Industry

Biotechnology

Listed Stock Exchange

Euronext Paris

Contact Investor Relations Department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.